Reuters logo
BRIEF-U.S. FDA grants fast track designation to Pluristem's PLX-PAD for treating Critical Limb Ischemia
September 18, 2017 / 11:37 AM / in a month

BRIEF-U.S. FDA grants fast track designation to Pluristem's PLX-PAD for treating Critical Limb Ischemia

Sept 18 (Reuters) - Pluristem Therapeutics Inc

* U.S. FDA grants fast track designation to Pluristem’s PLX-PAD for the treatment of Critical Limb Ischemia (cli)

* Pluristem Therapeutics Inc - Pluristem’s ongoing phase III cli trial has been selected for accelerated approval pathways in both U.S. and Europe Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below